AVTX vs KEYS · P/E 0.0, rev $441.0K vs P/E 57, rev $4.98B
Avalo Therapeutics Inc (AVTX) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the AVTX and KEYS stock pages for the full models.
Not investment advice.